You make a good case. "Both have been in development for over 10 years. You expect miracles from EbolaCide in 3 months. Something's not right here."
That begs the question of why the company decided to even restart the Ebolacide project in the first place. Your line of logic suggests that it will be years away from being a useful product.
If that is the case, why would NNVC spend time and money on something that won't be available for the current outbreak or generate revenues for years?
Maybe they expect miracles from EbolaCides. Something's not right here.
No. I believe the claim long ago was that viricides could be adapted to a new virus in a few weeks. Truly a miracle. A great stock selling pitch. Unfortunately total bullshit. Flucide was going to be in clinical trials years ago. Tox tested years ago.
More total bullshit.
Perhaps Rawnoc will repost his screen shot of the bullshit timelines the company published from back in the early days of this train wreck.
News 
Market Data 
Discover 
